Page 222 - Genentech News Today

Aerami Therapeutics Appoints Lisa Yañez as Chief Executive Officer - read this article along with other careers information, tips and advice on BioSpace

MAINZ, GERMANY, December 21, 2022 — BioNTech SE (Nasdaq: BNTX, “BioNTech”) reached the next milestone in the establishment of scalable mRNA vaccine...

Investegate announcements from BioNTech SE, Update on First BioNTainer for African-based mRNA Manufacturing Facility

/PRNewswire/ -- DelveInsights Gastric Cancer Pipeline Insight – 2022 report provides comprehensive global coverage of available, marketed, and pipeline...

Diana Ernst, RPh, is the Editorial Director for MPR, part of the Haymarket Medical Network. Since 2003, Diana has worked to provide healthcare professionals with up-to-date drug information through MPR's print and digital offerings. She is a graduate of the Ernest Mario School of Pharmacy, Rutgers University.

Investegate announcements from F. Hoffmann-La Roche Ltd, FDA approves Roche’s Actemra for the treatment of COVID-19 in hospitalised adults

Heading into the week before Christmas, the United States Food and Drug Administration flagged Eli Lilly & Co. (NYSE:LLY) for a shortage of their new diabetes drug, Mounjaro.

A trial in advanced cervical cancer will be initiated in 4Q2023 with potential registrational intentDose-finding Phase 1/2a trial in 1st line patients with...

An extremely uncommon genetic condition called spinal muscular atrophy (SMA) damages the area of the central nervous system that regulates voluntary muscle...

The Institute for Healthcare Improvement, the American Medical Association, Race Forward and several partners launched Rise to Health to transform healthcare with shared solutions and collective actions.